WHO naming stem · suffix · 54 listed names
-adol/-adol-
This page was written with AI.
analgesics
Where it sits in a name
WHO writes the stem as -adol/-adol-. It has 2 spellings or places: adol at the end of the name (…adol); adol inside the name, with letters before and after it (…adol…).
Of the 54 names WHO lists under it, 39 carry adol at the end of the name, 15 carry adol inside the name, with letters before and after it.
All 54 names WHO lists under -adol/-adol-
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 4 of 54 names appear in these lists: 3 in the US list (FDA Drugs@FDA) and 2 in the EU central list (EMA); 2 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- acetylmethadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alimadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alphacetylmethadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- alphamethadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- apadolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- asimadolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- axomadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- befiradolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- betacetylmethadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- betamethadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- bromadolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cebranopadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ciprefadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ciramadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cloracetadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- desmetramadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dibusadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- dimenoxadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- diproxadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- eluxadolineUS brands: VIBERZI
- enadolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- faxeladolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- filenadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- flumexadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- fluradolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gaboxadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- indantadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- insalmadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- levacetylmethadolUS brands: none found
- levonantradolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lexanopadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lorcinadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- moxadolenNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- myfadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nafoxadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nantradolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nerbacadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- noracymethadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oxapadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- picenadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pinadolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pipradimadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pipramadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pravadolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- profadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- radolmidineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ruzadolaneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- spiradolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tapentadolEU (central) brands: none found
- tazadoleneNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tolpadolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- tramadolUS brands: CONZIP, QDOLO (discontinued in FDA listings), RYBIX ODT (discontinued in FDA listings), RYZOLT (discontinued in FDA listings), ULTRAM (discontinued in FDA listings), ULTRAM ER (discontinued in FDA listings)in combination: SEGLENTIS (discontinued in FDA listings) with celecoxib; ULTRACET (discontinued in FDA listings) with acetaminophenEU (central) brands: none found
- vadolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- veradolineNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Names with these letters that are not analgesics
WHO lists these 4 names under -adol/-adol-, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of -adol/-adol- does not apply.
- alfadolone
- hexapradolWHO’s note: CNS stimulant
- nadolol
- quinestradolWHO’s note: estrogenic
Same group, without the stem
WHO also lists this name under -adol/-adol-: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. It belongs to the same group of substances as the group (a) names above, yet it does not carry -adol/-adol-, so the name alone does not reveal the group.
- dimepheptanol
Decode another name
Decoded
myfadol
Listed INNCarries the WHO stem -adol/-adol-
- -adol/-adol-end of the nameWHO lists it hereWHO definition: analgesics
“myfadol” is an INN that WHO lists under -adol/-adol- in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -adol/-adol- (Part II B) and the 54 names (Part IV, group (a)), and the 4 not in accordance with it (group (b)) and 1 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.